ORAL NIFEDIPINE AND INTRAVENOUS LABETALOL FOR HYPERTENSIVE EMERGENCIES IN PREGNANCY : A COMPARATIVE STUDY

preprint OA: closed
📄 Open PDF View at publisher
AI-generated summary by claude@2026-07, 2026-07-16

Oral nifedipine achieved target blood pressure more rapidly with fewer doses and was as safe as intravenous labetalol for treating hypertensive emergencies in pregnancy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Background: - Hypertensive emergency in pregnancy is defined as persistent acute-onset, severe hypertension (Systolic BP >160 mmHg or diastolic BP >110 mmHg or both) in the setting of preeclampsia or eclampsia. Objective - Compare safety and efficacy of oral nifedipine and intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy Study design – a randomised comparative hospital based study conducted in Department of Obstetrics and Gynaecology, SMS Medical College, Jaipur from April 2018 to Nov 2018. Sample - 80 women with hypertensive emergencies Method- Divided into 2 groups of 40 each. Nifedipine grp received 10mg tab every 20 min till maximum of 5 doses and labetalol grp was given iv labetalol in escalating doses of 20, 40, 40,80 and 80mg every 20 min till a target BP was achieved. Main outcome measures – Better treatment for Hypertensive emergencies of pregnancy Results – In our study, mean time required to achieve target BP in nifedipine and labetalol group was 45+14.84 and 54+18.22 minutes (p value 0.018) respectively. Mean decrease in SBP after treatment was 59 ± 21.1 mmHg in Nifedipine group as compared to 42.25 ± 22.7 mmHg in Labetalol (p-value = 0.001). Also the mean decrease in DBP in nifedipine group was 37.5 ± 11.49 mmHg as compared to 27.75 ± 15.34 mmHg in labetalol group(p-value = 0.001). There were no significant differences between side effects and fetomaternal outcome. Conclusion- Oral Nifedipine controls hypertension more rapidly and with fewer doses and is as safe as iv Labetalol.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-06-13T06:42:57.164913+00:00